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Calorie Restriction (CR) is an intervention with 
complex, pleiotropic effects that influences a plethora of 
biological processes. Animals on a CR regimen show 
decreased fecundity, increased activity and foraging 
behavior, and a general increase in stress resistance. 
Most importantly, CR consistently increases life span in 
most of the species tested. The mechanisms underlying 
these varied responses to a decrease in calorie intake 






















































The fruit fly D. melanogaster has proven to be an 
invaluable tool in dissecting the molecular mechanisms  
of CR. Flies respond robustly with extended life spans 
when calories are limited. It has been suggested that it is  
the dilution of specific food constituents, i.e. yeast 
extract, that determines the life span of the fruit fly [2], 
as opposed to a reduction of total calories. However, the 
importance of this finding remains somewhat unclear 
(3), especially  in light of the fact that yeast extract is a 
importance of this finding remains somewhat unclear 
[3] especially in light of the fact that yeast extract is a  
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salts, lipids, hormones and other small molecules [4]. 
 
Nonetheless, using food dilution methodologies of CR, 
several genes have been linked to CR. Life span 
extending mutations in the insulin receptor substrate 
CHICO [5] were shown to be non-additive to the life 
span extending effects of CR. Decreased rpd3 [6] and 
dSir2 over expression [7] both extend life span in a CR-
related manner, corresponding to the observed down 
regulation of rpd3, and up regulation of dSir2 under CR 
conditions [6]. Most importantly, dSir2 null flies do not 
respond efficiently to CR [6]. Interestingly, the 
multitude of biological effects (fecundity, activity, etc.) 
of CR can be uncoupled from the life span extending 
effects of CR. dSir2 over expressing flies, while having 
extended life span, do not show any defects in 
fecundity. These data suggest that the life span 
extending effects of CR in flies are mediated at least in 
part by dSir2, while the effects on other physiological 
systems may branch off at points up stream of dSir2 in 
the CR signaling pathway [7]. 
 
We have recently identified the Drosophila homolog of 
the tumor suppressor p53 (Dmp53) as another candidate 
gene that might mediate the life span extending effects 
of CR. Expression of  dominant-negative (DN) versions 
of Dmp53 in the adult fly brain extends life span, but is 
not additive to the effects of CR. The life span 
extending effects of DN-Dmp53 are furthermore 
smaller than the life span extending effects of CR. DN-
Dmp53 long-lived flies show no decrease in fecundity 
or of physical activity, yet are resistant to oxidative 
stress. These data suggest that Dmp53 is one of the 
down stream elements of the CR signaling pathway [8]. 
 
Here we further examine the possible role of Dmp53 in 
the CR signaling pathway. Our results indicate that 
Dmp53 is part of the CR signaling mechanism. We 
show that DN-Dmp53- and dSir2-dependent life span 
extensions are not additive. Importantly, Dmp53 and 
dSir2 physically interact, suggesting that Dmp53 is a 
down stream target of dSir2 deacetylation activity. Our 
data provide for a molecular ordering of the known 
components of the CR pathway in fruit flies, and thus 





DN-Dmp53-dependent life span extension can 
be induced later in life and is reversible 
 
In  order to  better  understand  the dynamics of DN-
Dmp53-dependent-life span extension we made use of 
the inducible GeneSwitch System for conditional 
expression of the DN-Dmp53 constructs in the adult fly 
brain. Using this system, we switched flies from food 
containing RU486 to non-RU food, and vice-versa. 
When expression of the DN-Dmp53 constructs was 
induced from the day of eclosion, a 47% median life 
span extension was observed, which is consistent with 
earlier observations [8]. When expression was induced 
later, at 10 or 20 days of adult life, median life span was 
still extended, but to a smaller extent (29% and 12%, 
respectively, Figure 1A; for statistical analysis of all life 
span experiments please refer to Table 1). We then 
performed the reverse experiment by switching flies 
back to non-RU486 containing food to stop induction of 
DN-Dmp53. These flies also showed extended life span, 
but the extension was again smaller than life span 
extension of flies with continuous expression of DN-
Dmp53 (Figure 1B). While it is relatively easy to 
visualize the change in survivorship for flies switched at 
day 10, the differences for flies switched at day 20 was 
more subtle (Table 1). To further examine whether 
turning on or off DN-Dmp53 expression at day 20 has 
plastic, reversible effects on mortality, we compared 
age-specific mortality trajectories between cohorts. 
These data show that within 15-20 days after addition or 
removal of RU486 to day 20 flies there is a complete 
shift from the pre-switch mortality curve to the post-
switch mortality curve. When plotting age-specific 
mortality rates (µx) on a natural log scale, we observed 
that mortality trajectories of flies shifted from control 
food (EtOH solvent control) to food containing RU486 
(expression turned on at day 20), or shifted from RU486 
food to control food (expression turned off at day 20), 
converged and fully reverted to the mortality levels of 
flies constitutively held on RU486 food (“on”) or on 
control food (“off”), respectively (Figure 1C). We used 
Cox (proportional hazards) regression to analyze 
censored mortality data post-switch and to avoid 
making assumptions about the particular distribution 
(and thus shape) of mortality rates [9]. Twenty days 
after the switch, mortality trajectories of shifted and 
non-shifted flies converged fully and became 
indistinguishable from each other for both “on” and 
“off” treatments (day 20, switch off: p = 0.67; day 20, 
switch on: p = 0.16). Moreover, mortality trajectories of 
“off” (constitutively off and switched off) versus “on” 
(constitutively on and switched on) cohorts differed 
significantly (p = 0.0162) from each other (excluding 
the last 10 days of life), confirming convergence and the 
effectiveness of the “on” and “off” treatments.  The 
delay in convergence most likely reflects some latency 
in induction kinetics of the RU-dependent GeneSwitch 
system (as well as the stop of induction), which we have 
also observed using a lacZ-reporter (data not shown). 
This reversible shift in mortality rates is reminiscent of 
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low calorie food (and vice-versa; data not shown and [9, 
10]), further supporting the idea that DN-Dmp53 and 
CR might employ similar mechanisms to extend life 
span [8, 11].  
content are tested and mean life span is plotted against 
calorie content, the resulting curve of the DN-Dmp53 
expressing flies is shifted towards higher calorie content 
(Supplemental  Figure 1 and data not shown).  Together  
with the data from [8, 11], this suggests that DN-
Dmp53 is part of a CR life span extending pathway. In 
the fly, CR is also mediated at least in part by dSir2 [7]. 
Since the life span extending effects of DN-Dmp53 and 
CR, and of CR and dSir2 are not additive, we 
investigated whether DN-Dmp53 and dSir2 might be 
part of the same life span extending pathway by 
determining if life span extension induced by DN-
Dmp53 and dSir2 expression were also not additive.  
 
Life span extension by DN-Dmp53 and dSir2 
are not additive 
 
We have previously shown that life span extension by 
DN-Dmp53 expression is not additive to life span 
extension by CR treatment [8, 11]. In fact, when a 
variety of different  food  types  with  different  calorie  
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   












   
   

































The dSir2 line EP2300 used for these experiments 
contains a  UAS-sequences  carrying  P-element  that  is 
inserted in the dSir2 5’UTR. This permits the over exp-
ression of the normal dSir2 gene, including its comple-
ment of introns that may be important for efficient 
transcription and translation.  The region, in  which  this 
P-element is inserted, however, is shared by the DNA J-
H gene, whose transcriptome is arranged in the opposite 
direction. In order to verify that life span extension by 
EP2300 is indeed due to dSir2 over expression, we 
performed QPCR analysis of dSir2 over expressing flies. 
Under normal RU conditions used for life span experi-
ments, dSir2 was ~ 3fold up regulated, while DNA J-H 
was barely changed (Figure 2A). When the RU con-
centration was increased, dSir2 mRNA expression was 
accordingly increased (~ 5fold), while DNA J-H levels 
remained unchanged (Figure 2A). Increasing the RU 
concentration in the food further extends the life span of 
dSir2 expressing flies (Figure 2B, Table 1), compared to 
flies raised on normal RU486 concentrations. These data 
indicate that life span extension in the EP2300 line is 
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Next, we examined if DN-Dmp53 life span extension 
was additive to life span extension by dSir2. As shown 
in Figure 2C, no additive effects were observed when 
both proteins were over expressed in the adult nervous 
system, suggesting that the life span extending effects 
of DN-Dmp53 and dSir2 expression may be part of a 
common pathway related to CR.  
 
Life span extension by DN-Dmp53 and 
resveratrol are not additive 
 
Another method to activate Sir2 is by using small 
molecule activators of Sir2, such as resveratrol [12]. 
Resveratrol has been shown to extend life span of flies, 
yeast and worms [13, 14] utilizing a pathway similar to 
CR [6]. Importantly, in flies life span extension by 
resveratrol treatment is abolished in dSir2 null flies. 
These data suggest that resveratrol acts to extend life 
span in flies through a dSir2-dependent mechanism. 
Therefore, we  tested   whether   life   span extension by 
DN-Dmp53 and this dSir2 activator were additive. As 
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mammalian proteins may also occur with the fly 
homologs. To test this hypothesis, we expressed FLAG-
tagged wild type Dmp53 in the adult nervous system 
using the GeneSwitch system, as expression of wild 
type-Dmp53 during development is lethal [8]. After 
induction of wt-Dmp53 expression for ten days, heads 
were isolated and proteins extracted. Tagged Dmp53 
was immunoprecipitated with a FLAG-antibody. As can 
be seen in Figure 3A, endogenous dSir2 efficiently co-
immunoprecipitated with over expressed FLAG-
Dmp53, indicating that, as with their mammalian 
counterparts, dSir2 and Dmp53 physically interact.  
shown in Figure 2D, life span extensions by these two 
different treatments were not additive. Taken together,  
these results suggest that CR, dSir2 and DN-Dmp53 
share similar mechanisms of life span extension. 
 
dSir2 interacts with Dmp53 and deacetylates 
Dmp53-derived peptides 
 
In mammalian systems Sir2 and p53 have been shown 
to physically interact with each other [15, 16, 17]. This 
interaction leads to inhibition of p53 transcriptional 
activity. If dSir2 and Dmp53 indeed act together as a 
part of a CR-related pathway of life span extension in  
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Figure 3. Functional interaction between dSir2 and Dmp53. (A) Endogenous dSir2 physically interacts with Dmp53. A FLAG‐tagged
version of wild type Dmp53 was expressed in females during the first 10 days of adult life using the ELAV‐Switch driver. Head extracts were









   
   
   
   
   
In mammals, a consequence of the interaction between 
Sir2 and p53 is the deacetylation of p53 [15, 16, 17]. 
We therefore tested whether dSir2 is able to deacetylate 
acetylated peptides derived from human p53. 
Recombinant dSir2 was incubated as described [12] 
with human peptides from either p53 or histone H4. 
Both peptides were efficiently deacetylated in a NAD-
dependent reaction by dSir2. These reactions were 
inhibited by the addition of nicotinamide (Figure 3B). 
Next, we tested whether dSir2 is able to deacetylate 
peptides that were derived from Dmp53. Peptides were 
tested, which contain lysine residues that are conserved 
between the mouse, human and fly version of p53. 
These peptides (LSLK and SLKK) were efficiently 
deacetylated in a NAD- and dose-dependent manner  by  
dSir2 (Figure 3C). The dose response curves exhibited 
saturation kinetics, indicating that deacetylation is due 
to dSir2, not caused by unrelated hydrolysis of the 
acetyl-group.  
 
Finally, we tested the functional consequences of dSir2 
activation on Dmp53. We thus transfected wt-Dmp53 
into Drosophila S2 cells together with a p53-luciferase 
transcriptional reporter construct. The cells were then 
treated with the Sir2-activator resveratrol. Resveratrol 
inhibited Dmp53 transcriptional activity in a dose-
dependent fashion as evidenced by reduction of p53-
induced luciferase activity (Supplemental Figure 2). 
Taken together these data indicate that, in flies, just like 
in mammals, Dmp53 and dSir2 functionally interact.  
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Dmp53, extends life span when expressed in the adult 
nervous system. CR treatment of dSir2 null flies does 
not lead to life span extension [7]. When dSir2 and DN-
Dmp53 are expressed together, no additive effects on 
life span are observed (Figure 2). When dSir2 is 
activated through the use of resveratrol, similar results 
are observed. In support of our hypothesis, it has 
recently been shown in C. elegans that reduction of cep-
1 activity (the C. elegans p53 homolog) extends life 
span; this life span extension is not additive to the life 
span extending effects of Sir2.1 over expression [18].  
 
When expressed in the adult nervous system of the fruit 
fly, DN-Dmp53 initiates signaling events leading to 
extended life span. These events remain plastic, as 
expression of DN-Dmp53 even later in life leads to 
extended life spans and a corresponding shift in the 
mortality rate trajectory (Figure 1). Our previous data 
showed that life span extension through expression of 
DN-Dmp53 is not additive to the life span extending 
effects of CR [8, 11]. This suggests that the events 
triggered by DN-Dmp53 are mechanistically related to 
CR. Here we further explore the relationship between 
CR and Dmp53.  
 
Our data also shows that, as in mammalian systems [15, 
16, 17], in flies dSir2 and Dmp53 physically interact 
and dSir2 can efficiently deacetylate Dmp53-derived 
peptides (Figure 3). This deacetylation event  leads  to  
inhibition  of  Dmp53   transcriptional activity. These 
data indicate that Dmp53 and dSir2 share a similar life 
span extending mechanism. Unfortunately, we cannot 
answer the question of Dmp53 acetylation in response 
to CR conditions, as we are unable to measure Dmp53 
acetylation status in vivo with the currently available 
reagents. 
 
We have previously demonstrated that the life span 
extending effects of CR are partially mediated by dSir2 
























We propose a model for the life span extending effects 
of CR in flies (Figure 4). Our data indicate that there 
may be a dSir2-dependent and a dSir2-independent CR 
life span extension pathway, as CR increases life span 
to a greater extent than dSir2 or DN-Dmp53 expression 
by itself. The dSir2-dependent pathway is activated 
when, under CR conditions, activity of the histone 
deacetylase Rpd3 is decreased. This in turn leads to an 
increase in dSir2 activity by an as yet unknown 
mechanism [7]. Increased dSir2 activity results in 
increased deacetylation of Dmp53 and subsequent 
inhibition of its transcriptional activity. It is also 
possible that Dmp53 transcriptional activity, rather than 
being inhibited, is changed to a different set of target 
genes. How this change of Dmp53 activity can extend 
life span is currently unclear, but our recent results 
demonstrate that flies with decreased Dmp53 activity 
have lower activity of the insulin/insulin-like growth 
factor signaling pathway (IIS) in the fat body [11]. 
Reduction of IIS activity, either through the use of 
mutants [19] or fat body-specific dFoxO over 
expression [20, 21] results in flies with extended life 
spans. It is thus conceivable that Dmp53-mediated 
down regulation of IIS activity might account for the 
some of the life span extending effects of CR. However, 
the activity of IIS is not limited to the regulation of 
dFoxO. IIS leads to the activation of the protein kinase 
Akt, which regulates pleiotropic signaling outputs, 
including activation of the transcription factor FoxO 
(via direct FoxO phosphorylation) or the translation 






dSir2  is  up  regulated.  dSir2  activity  inhibits  Dmp53  (amongst
other  targets),  leading  to  life  span  extension.  The  more  up
stream a gene is in this pathway, the more likely it will mediate
more of the pleiotropic aspects of CR, while more down stream
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of components of the target of rapamycin (TOR) 
signaling pathway).  Both of these branches are capable 
of controlling life span [20, 21, 22]. Which elements of 
IIS are ultimately responsible for the observed life span 
extending effects of DN-Dmp53 is under investigation, 
especially in light of the fact that life span extension due 
to yeast extract restriction appears independent of 
dFoxO [23, 24]. 
 
Our data describing the association of Rpd3, Sir2 and 
p53 in the life span extending effects of CR provides a 
useful molecular genetic model that should be valuable 
in designing future experiments for the identification of 





Fly culture and strains. All flies were kept in a 
humidified, temperature-controlled incubator with 12 
hour on/off light cycle at 25˚C in vials containing 
standard cornmeal medium. The ELAV-GeneSwitch 
line was from H. Keshishian (Yale University, New 
Haven, CT); UAS-Dmp53-FLAG-myc was from M. 
Brodsky (University of Massachusetts, Worcester, MA). 
UAS-Dmp53-Ct, UAS-Dmp53-259H and dSir2
EP2300 
were from the Drosophila Stock Center (Bloomington, 
IN).  
 
Life span analysis. Flies were collected under light 
anesthesia, randomly divided into treatment groups and 
housed at a density of 25 males and 25 females each per 
vial. At least ten such vials were used per treatment as 
per [8]. Flies were passed every other day and the 
number of dead flies recorded. All life span experiments 
were performed on regular cornmeal food (2% yeast, 
10% sucrose, 5% cornmeal (all w/v)) without added live 
yeast, except where indicated. High and low calorie 
food contained varying amounts of each yeast and 
sucrose (w/v; from 0.2N (2%) to 1.5N (15%)), but no 
cornmeal [9]. For induction with the GeneSwitch 
system, RU486 (Sigma) was added directly to the food 
to a final concentration of 200µM. For experiments 
using high RU486 concentrations, RU486 was used at 
500µM. The same concentration of solvent was added 
to control food. For food-switch experiments, flies were 
raised on RU or non-RU food, respectively, and 
switched to the new food regimen at the ages indicated. 
 
Quantitative PCR. Total RNA was isolated from at least 
75 heads of 10-day old females using Trizol 
(Invitrogen) and further purified using the RNeasy kit 
(Qiagen). cDNA was generated with 0.5µg total RNA 
using the iScript cDNA synthesis kit (Bio-Rad) in a 
10µl reaction volume. 0.8µl of the iScript reaction was 
used as QPCR template. QPCR was performed on an 
ABI 7500 Real-Time PCR machine using the ABI 
SYBR-Green PCR master mix following the 
manufacturers instructions. Each QPCR reaction was 
performed using four biological replicates in triplicate 
each. The following primers were used: GAPDH-F: 
GAC GAA ATC AAG GCT AAG GTC G; GAPDH-R: 
AAT GGG TGT CGC TGA AGA AGT C; dSir2-F: 
TCA TCA AAA TGC TGG AGA CCA AGG; dSir2-R: 
TTA CTC GCT GAA TGC CTG CCA C; DNA J-H-F: 
ATA CGA CCT GTC CGA CTT GCG ATG; DNA J-
H-R: TTC TGC TCT ACG AAA CCA CTG CCC. 
 
Immunoprecipitation and Western Blot analysis. UAS-
Dmp53-FLAG-myc was expressed in the heads of adult 
flies for ten days using the ELAV-GeneSwitch driver. 
Approximately 75 heads per condition were isolated 
and homogenized in NP-40 lysis buffer (1% NP-40, 
20mM Tris pH 8.0, 137mM NaCl, 2mM EDTA, 10% 
glycerol) plus protease inhibitors (CompleteMini, 
Roche). 500µg protein extracts were incubated with 1µl 
anti-FLAG M2 antibody (Sigma). After overnight 
incubation at 4˚C, extracts were precipitated with 25µl 
Protein G-Sepharose beads (Sigma) for 30 minutes. 
Immunoprecipitations were resolved on a 12% SDS-
PAGE and transferred to nitrocellulose membranes 
(BioRad). Western blots were performed with anti-
FLAG M2 antibody (Sigma). Recombinant full-length 
dSir2 was used to immunize New Zealand White rabbits 
using Covance’s standard 118-day protocol (Covance 
Research Products, Denver, PA). Polyclonal antibodies 
to dSir2 were purified by affinity purification from 
serum using the Aminolink kit (Pierce) coupled to 
recombinant dSir2 protein as an affinity matrix. 
Specificity of the antibody was verified by Western blot 
against wild-type and Sir2 null fly extracts.  
 
Deacetylation Assays. Recombinant dSir2 was 
produced as described [14]. In short, His6-tagged 
recombinant dSir2 was purified from E. coli 
BL21(DE3) plysS cells harboring the pRSETc-dSir2 
plasmid (gift of S. Parkhurst). Cells were grown in LB 
medium containing antibiotics at 30°C to an OD600 of 
0.6-0.8. After addition of IPTG (1 mM), flasks were 
shifted to 16°C for 20 h. Cell pellets were resuspended 
in cold PBS buffer containing 300 mM NaCl, 0.5 mM 
DTT, 0.5 mM PMSF and EDTA-free protease inhibitor 
tablets and lysed by sonication. Ni
2+-NTA beads were 
added to the clarified extract and after 1-3 hours they 
were loaded on a column, washed with buffer (20 
volumes of 50 mM Tris. Cl pH 7.4, 200 mM NaCl, 30 
mM imidazole) then eluted with the same buffer 
containing 250 mM imidazole. Human p53- and human 
histone H4-derived peptides were obtained from 
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Biomol. Deacetylation assays were performed as 
described [12] using 1µl of recombinant dSir2 and 
500µM NAD (Sigma). Released fluorescence was 
measured using a 96-well plate reader (Biotek 
Instruments) and plotted as relative fluorescence 
compared to background (Relative Light Units, RLU). 
 
Tissue culture. Schneider S2 cells were cultured in 
Schneider’s Drosophila Medium plus 10% FCS, 
1%Penicillin/Streptomycin, 10% L-glutamine 
(Invitrogen). Cells were transfected using FuGene6 
(Roche) with pMT-Dmp53-GFP and stable transfectants 
were selected using Hygromycin (Roche). Three 
independently derived lines were used for reporter 
assays. 1x10
6 cells of those stable transfectants were 
transfected with 0.2µg p53-Luc (Stratagene) or with 0.2 
µg p53-Luc and 0.2µg pRL-SV40 (Promega) in 
triplicate. After overnight incubation, cells were 
induced with 500µM MgSO4 and indicated amounts of 
resveratrol for 4hrs. Lysates were either normalized for 
Dmp53 expression by α-GFP western blot or by 
measuring renilla luciferase activity. Luciferase 
activities were normalized on the reporter activity of 
Dmp53 expressing cells without drug treatment. 
Luciferase activity was assayed using the Dual 
Luciferase Assay System (Promega) per manufacturers 
instructions on a TD20/20 luminometer (Turner 
Designs). 
Statistics. Log rank tests, were performed using the 
Prism suit of biostatistical software (GraphPad, San 
Diego). Maximum life span was calculated as the 
median life span of the longest surviving 10% of the 
population. Age-specific instantaneous mortality rate 
was estimated as ln((μx ) ≈ ln(-ln[1-Dx/Nx]), where Dx is 
the number of dead flies in a given census interval [25].  
We analyzed mortality rates using Cox regression 
(proportional hazards [26] implemented in JMP IN 5.1. 
statistical software (SAS Institute [27]). For clarity, we 
smoothed age-specific mortality rates as (ln(μx) using 
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and  shortened  life  spans  at  lower  food  concentrations
(underfeeding/starvation) and higher food concentrations
(overfeeding). The curve for DN‐Dmp53 expressing flies is












   




















































Supplemental  Figure  3.  The  Sir2  activating  drug
resveratrol inhibits Dmp53 transcriptional activity.
Drosophila  Schneider  S2  cells  stably  expressing  an





the  indicated  doses  or  solvent  control.  All  luciferase
activity induction was normalized to control treated cells.
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